Literature DB >> 1296016

Assessing the economic value of antihypertensive medicines.

M Drummond1, D Coyle.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1296016

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  6 in total

Review 1.  Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors:  E Ambrosioni
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?

Authors:  D Coyle; K Tolley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

3.  An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Application to the United Kingdom.

Authors:  S Hummel; J Piercy; R Wright; A Davie; A Bagust; J McMurray
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

Review 4.  Noncompliance with antihypertensive therapy. Economic consequences.

Authors:  T L Skaer; D A Sclar; L M Robison
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

Review 5.  Economics of hypertension control. World Hypertension League.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

6.  Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy.

Authors:  Gregory Hess; Jerrold Hill; Helen Lau; Homa Dastani; Paresh Chaudhari
Journal:  P T       Date:  2008-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.